We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
-14.64%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$683B
AUM Growth
-$118B
Cap. Flow
+$16.8B
Cap. Flow %
2.46%
Top 10 Hldgs %
22.55%
Holding
5,106
New
132
Increased
2,878
Reduced
1,465
Closed
89

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$956M
2
AAPL icon
Apple
AAPL
+$935M
3
WBD icon
Warner Bros
WBD
+$783M
4
HD icon
Home Depot
HD
+$626M
5
AMZN icon
Amazon
AMZN
+$476M

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Healthcare 14.76%
3 Financials 13.17%
4 Consumer Discretionary 10.3%
5 Industrials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XTNT icon
4976
Xtant Medical Holdings
XTNT
$57.7M
$12K ﹤0.01%
23,593
+2,389
+11% +$1.42K
MITO
4977
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$12K ﹤0.01%
48,791
MKD
4978
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$12K ﹤0.01%
22,220
-2
-0% -$3
THMO
4979
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$11K ﹤0.01%
964
LMNL
4980
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
$11K ﹤0.01%
2,274
AYLA
4981
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$11K ﹤0.01%
10,596
VLNS
4982
DELISTED
The Valens Company, Inc. Common Shares
VLNS
$11K ﹤0.01%
18,380
EQOS
4983
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$11K ﹤0.01%
13,223
GDC icon
4984
GD Culture Group
GDC
$6.54M
$10K ﹤0.01%
2
LGHL
4985
Lion Group Holding
LGHL
$1.02M
0
RCON icon
4986
Recon Technology
RCON
$34.4M
$10K ﹤0.01%
840
VGFC
4987
DELISTED
The Very Good Food Company
VGFC
$10K ﹤0.01%
42,576
NCNA
4988
NuCana
NCNA
$5.37M
$9K ﹤0.01%
2
CYTO
4989
DELISTED
Altamira Therapeutics Ltd
CYTO
$9K ﹤0.01%
47
PBLA
4990
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$9K ﹤0.01%
1
CHNR icon
4991
China Natural Resources
CHNR
$4.66M
$8K ﹤0.01%
303
NCEL
4992
NewcelX Ltd
NCEL
$19.7M
$8K ﹤0.01%
36
ZNB
4993
Zeta Network Group
ZNB
$535K
0
ATHE
4994
Alterity Therapeutics
ATHE
$83M
$7K ﹤0.01%
1,213
MTC icon
4995
MMTec
MTC
$373M
$7K ﹤0.01%
335
AIOS
4996
AIOS Tech
AIOS
$41.1M
$7K ﹤0.01%
56
VS icon
4997
Versus Systems
VS
$8.14M
$7K ﹤0.01%
75
PHCF
4998
DELISTED
Puhui Wealth Investment Management Co., Ltd.
PHCF
$7K ﹤0.01%
1,991
NBRV
4999
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$7K ﹤0.01%
1,710
FIEE
5000
FiEE Inc
FIEE
$25.1M
$7K ﹤0.01%
751
+103
+16% +$1.45K

Similar funds

Geode Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geode Capital Management held 5,106 positions worth $683B, down 15% from $801B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2022: portfolio turnover was 4.3%. Geode Capital Management opened 132 new positions and exited 89, leaving the 5,106-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q2 2022 buy was Aspen Technology Inc: 402,046 shares worth $74M.
  • Geode Capital Management added most to Microsoft in Q2 2022, an estimated $956M increase.
  • Geode Capital Management's biggest Q2 2022 reduction was AT&T, cutting an estimated $734M.
  • Geode Capital Management fully exited Cerner Corp in Q2 2022, selling an estimated $600M.
  • Geode Capital Management's ten largest holdings make up 23% of its $683B portfolio in Q2 2022.
  • Geode Capital Management opened 132 new positions and closed 89 in Q2 2022.
  • Geode Capital Management's portfolio value fell 15% quarter-over-quarter to $683B.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.